International Biotechnology Trust PLC Biogen Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Biogen Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 40,200 shares of BIIB stock, worth $5.99 Million. This represents 3.51% of its overall portfolio holdings.

Number of Shares

40,200

Previous 11,000 265.45%

Holding current value

$5.99 Million

Previous $3.13 Million 229.75%

% of portfolio

3.51%

Previous 0.98%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $7.4 Million - $8.35 Million	29,200 Added 265.45%	40,200 $10.3 Million
Q2 2023 Aug 08, 2023	SELL	$275.25 - $318.06 $2.86 Million - $3.31 Million	-10,400 Reduced 48.6%	11,000 $3.13 Million
Q4 2022 Feb 01, 2023	SELL	$252.44 - $306.72 $6.08 Million - $7.39 Million	-24,100 Reduced 52.97%	21,400 $5.93 Million
Q3 2022 Nov 08, 2022	BUY	$194.69 - $268.46 $6.79 Million - $9.37 Million	34,894 Added 329.0%	45,500 $12.1 Million
Q2 2022 Aug 16, 2022	BUY	$187.54 - $223.02 $1.99 Million - $2.37 Million	10,606 New	10,606 $52 Million
Q1 2022 May 20, 2022	SELL	$193.77 - $244.14 $9.2 Million - $11.6 Million	-47,500 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $4.93 Million - $6.33 Million	22,000 Added 86.27%	47,500 $11.4 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $6.51 Million - $8.49 Million	-23,000 Reduced 47.42%	25,500 $7.21 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $3.81 Million - $4.47 Million	15,700 Added 47.87%	48,500 $13.6 Million
Q4 2020 Feb 19, 2021	SELL	$236.26 - $355.63 $2.55 Million - $3.84 Million	-10,800 Reduced 24.77%	32,800 $8.02 Million
Q3 2020 Dec 01, 2020	SELL	$264.77 - $305.71 $2.01 Million - $2.32 Million	-7,600 Reduced 14.84%	43,600 $12.3 Million
Q2 2020 Jul 14, 2020	BUY	$258.66 - $342.55 $1.42 Million - $1.88 Million	5,500 Added 12.04%	51,200 $13.3 Million
Q4 2019 May 18, 2020	BUY	$220.06 - $304.07 $3.08 Million - $4.26 Million	14,000 Added 44.16%	45,700 $13.6 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $2.39 Million - $2.68 Million	-11,000 Reduced 25.76%	31,700 $7.38 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $7.28 Million - $8.03 Million	33,200 Added 349.47%	42,700 $9.99 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $1.67 Million - $2.61 Million	-7,700 Reduced 44.77%	9,500 $2.25 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $25.3 Million - $32 Million	-90,800 Reduced 84.07%	17,200 $4.06 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $21.1 Million - $27.6 Million	71,792 Added 198.28%	108,000 $710,000
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $2.42 Million - $2.88 Million	-9,400 Reduced 20.61%	36,208 $10.5 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $5.05 Million - $7.14 Million	-19,400 Reduced 29.84%	45,608 $12.5 Million
Q4 2017 Mar 02, 2018	SELL	$307.64 - $344.58 $2 Million - $2.24 Million	-6,500 Reduced 9.09%	65,008 $20.7 Million
Q3 2017 Mar 02, 2018	BUY	$281.15 - $329.69 $2.92 Million - $3.43 Million	10,400 Added 17.02%	71,508 $22.4 Million
Q2 2017 Mar 02, 2018	SELL	N/A	-14,300 Reduced 18.96%	61,108 $16.6 Million
Q1 2017 Mar 02, 2018	BUY	N/A	9,500 Added 14.41%	75,408 $20.6 Million
Q4 2016 Mar 02, 2018	BUY	N/A	65,908	65,908 $18.7 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Biogen Inc. Transaction History